Implant Sciences Corp. (OTCMKTS:IMSC) Goes Up by Another Notch
Yesterday’s session smiled upon Implant Sciences Corp. (OTCMKTS:IMSC) and the stock price of the company inched a little higher, closing the day another 2% up. Share volume was deflated compared to the Monday but remained well above the monthly average for the stock.
With its relatively high price per share for an OTC company, IMSC managed to generate significant dollar volume in the last session. Tuesday was the fourth green close in a row that the stock managed, obviously starting to garner greater investor attention. Is there lot to be excited about with IMSC, though?
The company is actively trying to sell its detection products with moderate success. However, moderate success doesn’t cut it when your business costs you so much. Here is a brief rundown of the numbers posted in IMSC‘s quarterly report for Q1 of this year:
- ZERO in cash, $1.29 million in restricted cash and investments
- $46 million in current liabilities
- $1.26 million in quarterly revenue
- $5.3 million in quarterly net loss
- $144 million in accumulated deficit
The company’s lack of cash on hand can be considered a serious negative. The revenue figure, sizable and likeable as it is on its own, is chewed through by costs and expenses almost five times greater, leaving the company in an increasingly deeper hole of debt.
Yesterday’s session seemed to have more losers than gainers among its most heavily traded stocks. Jammin Java Corp. (OTCMKTS:JAMN) slumped about 9% in Tuesday’s market. Recent massive pump Xumanii, Inc. (OTCMKTS:XUII) also dropped 13% down in the previous market session.
IMSC is trading 1.8% up in today’s early market.
